期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

危重患者连续性肾替代治疗中常用抗感染药物的剂量选择 被引量：3

原文传递
导出
摘要 1977年,Kramer等[1]首先将连续性动-静脉血液滤过（CAVH）技术应用于临床,很大程度上克服了传统的间歇性血液透析存在的＂非生理性＂治疗的缺陷,标志着一种新的连续性肾替代治疗（CRRT）技术的诞生。CRRT可大量清除体内炎性介质,
作者 张志国 李云霞 万建建 王静 王向峰 孙淑娟
机构地区 解放军第 山东省千佛山医院药剂科 济南市第二人民医院药剂科
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2011年第19期4188-4190,共3页 Chinese Journal of Nosocomiology
关键词 连续性肾替代治疗 抗感染药物 剂量
分类号 R978.1 [医药卫生—药品]
  • 相关文献

参考文献28

  • 1Kramer P, Wigger W, Rieger J, et al. Arteriovenous hemofiltration:a new and simple method for treatment of over hydrated patients resistant to diuretics[J]. Klin Wochenschr, 1977,55 (22) : 1121-1122.
  • 2Li AM,Gomersall CD, Cboi G, et al. A systematic review of antibiotic dosing regimens for septic patients receiving continuous renal replacement therapy:do current studies supply sufficient data[J]. J Antimicrob Chemother, 2009,64 (5) : 929-937.
  • 3Ricci Z, Ronco C, D'Amico G, et al. Practice patterns in the management of acute renal failure in the critically ill patient: an international survey[J]. Nephrol Dial Transplant,2006,21 (3) :690-696.
  • 4Joy MS, Matzke GR, Frye RF,et al. Determinants of vancomycin clearance by continuous venovenous hemofiltration and continuous venovenous hemodialysis[J]. Am J Kidney Dis, 1998,31(6) :1019-1027.
  • 5Mueller SC, MajchevPeszynska J, Hickstein H, et al. Pharmacokinetics of piperacillin tazobaetam in anuric intensive care patients during continuous venovenous hemodialysis[J]. Antimicrob Agents Chemother, 2002,46(5) : 1557-1560.
  • 6Valtonen M,Tiula E, Takkunem O,et al. Elimination of piperacillin/tazobaetam combination during continuous venovenous haemofiltration and haemodialfiltration in patients with acute renal failure[J]. J Antimierob Chemother,2001,48(6) : 881-885.
  • 7van der Werf T S,Mulder PO,Zijlstra JG,et al. Pharmacokinetics of piperacillin and tazobactam in critically ill patients with renal failure, treated with continuous veno-venous hemofiltration (CVVH) [J]. Intensive Care Med, 1997,23 (8) : 873- 877.
  • 8Cappellier G, Cornette C, Boillot A, et al. Removal of piperacillin in critically ill patients undergoing continuous venovenous hemofiltration[J]. Crit Care Med, 1998,26(1) : 88-91.
  • 9Trotman RL,Williamson JC,Shoemaker DM,et al. Antibiotic dosing in critically ill adult patients receiving continuous renal replacement therapy[J]. Clin Infect Dis, 2005,41 (8) : 1159- 1166.
  • 10Kroh UF, Lennartz H, Edwards D,et al. Pharmacokinetics of ceftriaxone in patients undergoing continuous veno-venous hemofiltration[J]. J Clin Pharmacol,1996,36(12) :1114-1119.

同被引文献62

  • 1查艳,周力,刘琦,张永宏,马启玲.反复短时血滤疗法对重症急性胰腺炎细胞因子的影响[J].贵阳医学院学报,2005,30(1):36-38. 被引量：8
  • 2杨志福,文爱东,王禾,秦卫军,杨晓剑,窦科峰.替硝唑注射液在肝肾胰联合移植伴连续性肾脏替代治疗患者体内的药代动力学[J].中国临床药理学杂志,2006,22(6):418-421. 被引量：1
  • 3卢玉宝,史忠.连续性肾脏替代治疗(CRRT)的临床治疗进展[J].重庆医学,2007,36(18):1822-1824. 被引量：48
  • 4林善琰.当代肾脏病学[M].上海:上海科学技术教育出版社,2001.837.
  • 5Brunet S, Leblanc M, Geadah D, et al. Diffusive and con- vective solute clearances during continuous renal replace- ment therapy at various dialysate and ultrafiltration flow rates [J]. Am J Kidney Dis, 1999, 34 (3): 486-492.
  • 6Pea F, Viale P, Pavan F, et al. Pharmackkinetic consider- ations for antimicrobial theray in patients receiving re- nal replacement therapy[J]. Cline Pharmacokinet, 2007, 46(12): 997-1038.
  • 7Finkel K W, Podoll A S. Complications of continuous renal replacement therapy[J]. Semin Dial, 2009, 22(2): 155-159.
  • 8Liangos O, Wald R, O'Bell J W, et al. Epidemiology and outcomes of acute renal failure in hospitalized patients: a national survey[J]. Clin J Am Soc Nephrol, 2006, 1(1): 43-51.
  • 9Pannu N, Klarenbach S, Wiebe N, et al. Renal replace- ment therapy in patients with acute renal failure: a sys- tematic review[J]. JAMA, 2008, 299 (7): 793-805.
  • 10Bagshaw S M, Wald R, Barton J, et al. Clinical factorsassociated with initiation of renal replacement therapy in critically ill patients with acute kidney inju:,a prospec- tive multicenter observational study[J]. J Crit Care, 2012, 27(3) : 268-275.

引证文献3

二级引证文献15

中华医院感染学杂志
2011年 第19期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部